Ryaltris 25 microgram / actuation + 600 microgram / actuation nasal spray, suspension

Licence status
Authorised: 16/07/2021
Active substances
Mometasone furoate, Olopatadine
Dosage Form
Nasal spray, suspension
Licence number
PA1543/002/001
Licence holder
Glenmark Pharmaceuticals s.r.o.

Product documents

Licence information

ATC code
R01AD59 mometasone, combinations
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/07/2021